GR3036294T3 - Neurotrophic and antiproliferative compounds - Google Patents

Neurotrophic and antiproliferative compounds

Info

Publication number
GR3036294T3
GR3036294T3 GR20010401144T GR20010401144T GR3036294T3 GR 3036294 T3 GR3036294 T3 GR 3036294T3 GR 20010401144 T GR20010401144 T GR 20010401144T GR 20010401144 T GR20010401144 T GR 20010401144T GR 3036294 T3 GR3036294 T3 GR 3036294T3
Authority
GR
Greece
Prior art keywords
neurotrophic
antiproliferative compounds
compounds
antiproliferative
useful
Prior art date
Application number
GR20010401144T
Other languages
English (en)
Inventor
Ciaran M Regan
Heinz Nau
Original Assignee
American Biogenetic Sciences
Univ Dublin
Ciaran M Regan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26970481&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR3036294(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/298,108 external-priority patent/US5672746A/en
Application filed by American Biogenetic Sciences, Univ Dublin, Ciaran M Regan filed Critical American Biogenetic Sciences
Publication of GR3036294T3 publication Critical patent/GR3036294T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/18—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon triple bonds as unsaturation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/377—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups
    • C07C51/38—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups by decarboxylation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/126—Acids containing more than four carbon atoms
    • C07C53/128—Acids containing more than four carbon atoms the carboxylic group being bound to a carbon atom bound to at least two other carbon atoms, e.g. neo-acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/03—Monocarboxylic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Psychology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Farming Of Fish And Shellfish (AREA)
GR20010401144T 1994-08-30 2001-07-27 Neurotrophic and antiproliferative compounds GR3036294T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/298,108 US5672746A (en) 1994-08-30 1994-08-30 Antiproliferative and neurotrophic molecules
US08/446,481 US6300373B1 (en) 1993-09-10 1995-05-22 Antiproliferative and neurotrophic molecules
PCT/US1995/010775 WO1996006821A1 (en) 1994-08-30 1995-08-25 Neurotrophic and antiproliferative compounds

Publications (1)

Publication Number Publication Date
GR3036294T3 true GR3036294T3 (en) 2001-10-31

Family

ID=26970481

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20010401144T GR3036294T3 (en) 1994-08-30 2001-07-27 Neurotrophic and antiproliferative compounds

Country Status (14)

Country Link
US (3) US6300373B1 (el)
EP (1) EP0778820B1 (el)
JP (2) JP3914568B2 (el)
AT (1) ATE200890T1 (el)
AU (1) AU3415195A (el)
CA (1) CA2198728A1 (el)
DE (1) DE69520832T2 (el)
DK (1) DK0778820T3 (el)
ES (1) ES2158124T3 (el)
GR (1) GR3036294T3 (el)
HK (1) HK1008882A1 (el)
NZ (2) NZ334119A (el)
PT (1) PT778820E (el)
WO (1) WO1996006821A1 (el)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6300373B1 (en) * 1993-09-10 2001-10-09 American Biogenetic Sciences, Inc. Antiproliferative and neurotrophic molecules
EP1170008A1 (en) 2000-07-07 2002-01-09 Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus Valproic acid and derivatives thereof as histone deacetylase inhibitors
EP1293205A1 (en) * 2001-09-18 2003-03-19 G2M Cancer Drugs AG Valproic acid and derivatives thereof for the combination therapy of human cancers, for the treatment of tumour metastasis and minimal residual disease
WO2003030831A2 (en) * 2001-10-11 2003-04-17 Protein Design Labs, Inc. Treatment of prostate cancer by inhibitors of atp synthase
AU2003289782A1 (en) * 2002-12-16 2004-07-09 The University Of British Columbia Valproic acid analogues and pharmaceutical compositions thereof
BRPI0520686A2 (pt) * 2005-11-16 2009-05-19 Univ Mexico Nacional Autonoma uso de agentes modificantes de transcriptoma associado a quimioterapia ou radioterapia contra o cáncer
BRPI0717972A2 (pt) * 2006-11-01 2013-11-12 Pronova Biopharma Norge As Lipídeos de ômega-3 alfa-substituídos que são ativadores ou moduladores do receptor ativado por proliferadores de peroxissoma (ppar)
ES2342997B1 (es) * 2008-12-09 2011-06-06 Universitat De Les Illes Balears Alpha derivados de acidos grasos cis-monoinsaturados para ser usados como medicamento.

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1066578B (de) 1959-10-08 Dr. rer. nat. Karl Ernst Schulte, Berlin - Dahlem Verfahren zur Herstellung von ungesättigten Lactonen
FR2442M (fr) 1962-10-17 1964-04-06 Henry Eugene L'acide dipropylacétique et ses dérivés en tant que nouveuax médicaments dépresseurs du systeme nerveux central.
GB1051322A (el) * 1967-08-09
US3701729A (en) 1970-06-01 1972-10-31 Tenneco Chem Oil-soluble mixed copper soap products
US3847956A (en) 1973-04-06 1974-11-12 Us Agriculture 2-hydroperoxycarboxylic acids and their preparation
US3932285A (en) 1973-10-03 1976-01-13 Tenneco Chemicals, Inc. Chromium salt compositions and a process for their production
US4025649A (en) 1974-08-19 1977-05-24 Labaz Acetic acid derivatives having pharmacological activity and compositions containing the same
US4129599A (en) 1975-04-28 1978-12-12 The Board Of Trustees Of Leland Stanford Jr. University A-Norsteroids
JPS5650116A (en) 1979-09-27 1981-05-07 Tohoku Electric Power Co Inc Manufacture of calcined gypsum
JPS5680116A (en) 1979-12-05 1981-07-01 Sanyo Electric Co Ltd Manufacture of substrate for magnetic bubble
JPH0233704B2 (ja) 1982-10-07 1990-07-30 Takeda Chemical Industries Ltd Chikanbinirukarubonsanjudotai
FR2599737B1 (fr) 1986-06-10 1989-05-19 Sanofi Sa Procede pour la fixation de groupes alkyles, alkenyles, cycloalkyles ou aralkyles sur une chaine carbonee portant un groupement fonctionnel
JPH01135740A (ja) 1987-11-24 1989-05-29 Nippon Mining Co Ltd 光学活性を有する２―アルキル―１―アルカン酸の製造方法
US5021398A (en) 1989-10-26 1991-06-04 Amp Incorporated Method of forming patterned oxide superconducting films
DE4231085A1 (de) * 1992-09-12 1994-03-17 Desitin Arzneimittel Gmbh VPA-analoge Antiepileptika
JPH08503732A (ja) 1992-11-30 1996-04-23 ザ、プロクター、エンド、ギャンブル、カンパニー 特選の石鹸を含有する高起泡性洗剤組成物
JP3304459B2 (ja) 1992-12-18 2002-07-22 松下電器産業株式会社 電解コンデンサ駆動用電解液およびそれを用いた電解コンデンサ
DK0632008T3 (da) 1993-06-01 1998-09-23 Ono Pharmaceutical Co Pentansyrederivater
US6300373B1 (en) * 1993-09-10 2001-10-09 American Biogenetic Sciences, Inc. Antiproliferative and neurotrophic molecules
WO1995033044A1 (en) 1994-05-27 1995-12-07 The Procter & Gamble Company Liquid laundry detergent compositions comprising specially selected soaps

Also Published As

Publication number Publication date
US6274624B1 (en) 2001-08-14
NZ334119A (en) 2000-09-29
US20020013367A1 (en) 2002-01-31
DK0778820T3 (da) 2001-08-20
ATE200890T1 (de) 2001-05-15
MX9701594A (es) 1998-07-31
EP0778820B1 (en) 2001-05-02
NZ292388A (en) 1999-03-29
HK1008882A1 (en) 1999-05-21
ES2158124T3 (es) 2001-09-01
PT778820E (pt) 2001-10-31
US6300373B1 (en) 2001-10-09
DE69520832D1 (de) 2001-06-07
CA2198728A1 (en) 1996-03-07
JPH10505064A (ja) 1998-05-19
DE69520832T2 (de) 2001-08-09
JP3914568B2 (ja) 2007-05-16
WO1996006821A1 (en) 1996-03-07
AU3415195A (en) 1996-03-22
EP0778820A1 (en) 1997-06-18
JP2007091748A (ja) 2007-04-12

Similar Documents

Publication Publication Date Title
PL324313A1 (en) 10-axcyloxy 10,11-dihydrobenz/b,f/azepin-5-carboxyamides useful in treating nervous system disorders
CY2424B1 (en) Pharmaceutical composition for use in treatment ofdiabetes.
IS1852B (is) Spíró-asabísýklísk efnasambönd sem eru gagnleg við meðferð
HK1150762A1 (en) Arsenic trioxide for use in the treatment of leukaemia
GB2275264B (en) Waste treatment process employing oxidation
IL121170A0 (en) Compositions for the treatment of dermatological disorders
EP0673384A4 (en) POLYPEPTIDES USEFUL IN TREATING INFLAMMABLE DISEASES.
ZA965938B (en) Use of MP52 of MP121 for the treatment and prevention of diseases of the nervous system.
GR3036294T3 (en) Neurotrophic and antiproliferative compounds
ZA932415B (en) Compounds for the treatment of neurodegenerative disorders
EP0626162A3 (de) Krankenbett.
PL322625A1 (en) Benzamides for treating neurodegenerative disorders
IL112024A0 (en) Pharmaceutical compositions for treating gastointestinal motility disorders
EP0638357A3 (de) Vorrichtung zur kontinuierlichen Herstellung von Polyacetalen und ihre Verwendung.
EP0672457A3 (de) Verfahren zur rückstandsfreien Abfallbehandlung.
EP0679397A3 (de) Verwendung von substituierten Aminen zur Behandlung von Hirnleistungsstörungen.
EP0155934A4 (en) Pharmaceutical compositions for the treatment of disorders caused by human drugs.
HUP0003566A3 (en) Process for producing dosage form and the obtained product
IL101622A0 (en) Pharmaceutical compositions
EP0679719A3 (de) Verfahren zur biologischen Behandlung von organische Stoffe enthaltenden Abfällen.
HUT76806A (en) Technetium-sulphonamide complexes, their use, pharmaceutical agents containing them, and process for producing the complexes and agents
FR2671563B1 (fr) Procede de traitements metallurgiques.
FI961228A0 (fi) Puristinosalaite
GB2354946B (en) Means for the treatment of prion disease
ZA964180B (en) Synergistic treatment for Parkinsonism.

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees